How many drugs treat Tetanus Adjunct Treatment?

Drug Landscape tracks 3 marketed treatments for Tetanus Adjunct Treatment (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/tetanus-adjunct-treatment.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Tetanus Adjunct Treatment — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tetanus Adjunct Treatment (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Tetanus Adjunct Treatment, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Nembutal Sodium	PENTOBARBITAL	Oak Pharms	pentobarbital	GABA-A receptor alpha-1/beta-2/gamma-2	1973-01-01
Robaxin	METHOCARBAMOL	Hikma	Muscle Relaxant [EPC]	Carbonic anhydrase 1	1957-01-01
Thorazine	chlorpromazine	Generic (originally Rhône-Poulenc/Sanofi)	Typical antipsychotic (first-generation, phenothiazine)	Aldehyde oxidase, Sphingomyelin phosphodiesterase, 5-hydroxytryptamine receptor 1E	1954-03-26

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Generic (originally Rhône-Poulenc/Sanofi) · 1 drug in Tetanus Adjunct Treatment
Hikma · 1 drug in Tetanus Adjunct Treatment
Oak Pharms · 1 drug in Tetanus Adjunct Treatment

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Tetanus Adjunct Treatment:

Cite this brief

Drug Landscape (2026). Tetanus Adjunct Treatment — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/tetanus-adjunct-treatment. Accessed 2026-06-10.

Tetanus Adjunct Treatment full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing